Estimate | OR | 95% CI | P value | ||
---|---|---|---|---|---|
Lower | Upper | ||||
Ethicus 2 study (2015–2016) vs. Ethicus 1 study (1999–2000) | 3.59 | 36.29 | 9.12 | 144.47 | < 0.001 |
Region | |||||
Central Europe vs. Northern Europe | − 0.20 | 0.82 | 0.42 | 1.59 | 0.56 |
Southern Europe vs. Northern Europe | − 1.13 | 0.32 | 0.15 | 0.68 | 0.003 |
Age | 0.03 | 1.02 | 1.02 | 1.03 | < 0.001 |
Sex, female vs. male | − 0.02 | 0.98 | 0.89 | 1.07 | 0.62 |
Physician religion | |||||
Catholic vs. none | 0.64 | 1.89 | 1.19 | 3.00 | 0.007 |
Jewish vs. none | 1.04 | 2.83 | 1.48 | 5.41 | 0.002 |
Greek orthodox vs. none | 0.55 | 1.74 | 0.97 | 3.10 | 0.06 |
Protestant vs. none | 0.87 | 2.39 | 1.42 | 4.04 | 0.001 |
Unknown vs. none | − 6.03 | 0.002 | 0.001 | 0.010 | < 0.001 |
Other vs. none | 0.26 | 1.30 | 0.75 | 2.25 | 0.35 |
Islam vs. none | 0.41 | 1.51 | 0.63 | 3.60 | 0.35 |
Acute diagnoses | |||||
Surgery vs. neurologic | − 0.13 | 0.88 | 0.62 | 1.23 | 0.45 |
Respiratory vs. neurologic | 0.49 | 1.64 | 1.16 | 2.32 | 0.006 |
Cardiovascular vs. neurologic | − 0.19 | 0.83 | 0.62 | 1.11 | 0.22 |
Gastrointestinal vs. neurologic | 0.68 | 1.98 | 1.40 | 2.81 | < 0.001 |
Metabolic vs. neurologic | 0.70 | 2.01 | 1.00 | 4.06 | 0.0502 |
Hematologic vs. neurologic | 0.48 | 1.62 | 0.71 | 3.74 | 0.26 |
Trauma vs. neurologic | − 0.32 | 0.73 | 0.51 | 1.05 | 0.09 |
Sepsis vs. neurologic | 0.65 | 1.92 | 1.25 | 2.94 | 0.003 |
Other vs. neurologic | 0.51 | 1.66 | 1.00 | 2.74 | 0.048 |
Chronic diseases | |||||
Cardiovascular diseases vs. none | 0.56 | 1.75 | 1.40 | 2.18 | < 0.001 |
Neurological-cognitive diseases–muscular vs. none | 0.74 | 2.09 | 1.25 | 3.48 | 0.005 |
Chest diseases vs. none | 0.91 | 2.48 | 1.80 | 3.40 | < 0.001 |
Kidney and urinary system diseases vs. none | 0.38 | 1.47 | 0.88 | 2.44 | 0.14 |
Digestive system vs. none | 1.49 | 4.46 | 2.72 | 7.29 | < 0.001 |
Immunologic system vs. none | 0.93 | 2.53 | 1.49 | 4.30 | 0.001 |
General history vs. none | 0.43 | 1.54 | 1.14 | 2.07 | 0.005 |
Cancer vs. none | 1.17 | 3.23 | 2.15 | 4.83 | < 0.001 |
Unknown vs. none | 1.30 | 3.67 | 1.56 | 8.65 | 0.003 |
End-of-life practice variables | |||||
Routine ICU family meetings: yes vs. no | − 0.03 | 0.97 | 0.52 | 1.79 | 0.91 |
Daily deliberation for appropriate level of ICU care: yes vs. no | 0.57 | 1.77 | 0.96 | 3.28 | 0.07 |
End-of-life (EOL) discussions during weekly (family) meetings: yes vs. no | − 0.61 | 0.55 | 0.30 | 0.99 | 0.047 |
Written triggers for limitations: yes vs. no | -0.14 | 0.87 | 0.41 | 1.86 | 0.72 |
Written ICU EOL guidelines: yes vs. no | − 0.65 | 0.52 | 0.31 | 0.87 | 0.013 |
Written ICU EOL protocols: yes vs. no | 2.71 | 15.08 | 3.88 | 58.59 | < 0.001 |
Palliative care consultations: yes vs. no | 0.97 | 2.63 | 1.23 | 5.60 | 0.012 |
Ethics consultations: yes vs. no | − 0.96 | 0.38 | 0.14 | 1.07 | 0.07 |
ICU staff taking communication courses: yes vs. no | 0.13 | 1.14 | 0.52 | 2.51 | 0.74 |
ICU staff taking bioethics courses: yes vs. no | − 0.19 | 0.83 | 0.19 | 3.57 | 0.80 |
Country EOL guidelines: yes vs. no | 0.14 | 1.16 | 0.53 | 2.50 | 0.72 |
Country EOL legislation: yes vs. no | 1.17 | 3.24 | 1.60 | 6.55 | 0.001 |
Intercept | − 1.54 | 0.21 | 0.08 | 0.59 | 0.003 |